Download 33rd Annual Meeting of the European Society for Paediatric

ESPID Reports and Reviews
CONTENTS
33rd Annual Meeting of ESPID
EDITORIAL BOARD
Co-Editors: Delane Shingadia and Nicole Ritz
Board Members
David Burgner (Melbourne,
Australia)
Kow-Tong Chen (Tainan,Taiwan)
Luisa Galli (Florence, Italy)
Steve Graham (Melbourne,
Australia)
Cristiana Nascimento-Carvalho
(Bahia, Brazil)
Ville Peltola (Turku, Finland)
Emmanuel Roilides (Thessaloniki,
Greece)
Ira Shah (Mumbai, India)
George Syrogiannopoulos
(Larissa, Greece)
Tobias Tenenbaum (Mannhein, Germany)
Marc Tebruegge (Southampton, UK)
Marceline van Furth (Amsterdam,
The Netherlands)
33rd Annual Meeting of the European Society for Paediatric
Infectious Diseases in Leipzig, Germany
Michael Borte, MD* and Volker Schuster, MD*†
T
he 33rd Annual Meeting of the European
Society for Paediatric Infectious Diseases (ESPID) was held in Leipzig, Germany,
from May 12 to 16, 2015 (Fig. 1).
Again, as before, the main theme was
Advances in Paediatric Infectious Diseases.
This topic was chosen because it offered
the chance to present innovative and important research in all areas of pediatric infectious diseases. Since its founding in 1983
(Cambridge, United Kingdom), ESPID has
grown to include more than 1000 members
from Europe and, increasingly, also from
other countries out of Europe. ESPID’s
annual meeting provides an excellent forum
for clinicians and scientists interested in the
many aspects of pediatric infectious diseases
including clinical practice, research, education and training. Two thousand one hundred
sixty-nine participants from all over the world
attended this meeting. This is markedly less
than for ESPID 2013 (Milan, 3363 attendees)
and ESPID 2014 (Dublin, 2665 attendees).
From the *Hospital for Children and Adolescents, St.
Georg Hospital; and †University of Leipzig, Leipzig, Germany.
The authors have no funding or conflicts of interest
to disclose.
Address for correspondence: Volker Schuster, MD,
Hospital for Children and Adolescents, University of Leipzig, Leibigstrasse 20a, D-4103,
Leipzig, Germany. E-mail: Volker.Schuster@
medizin.uni-leipzig.de.
Copyright © 2015 Wolters Kluwer Health, Inc. All
rights reserved.
ISSN: 0891-3668/16/3502-0209
DOI: 10.1097/INF.0000000000000985
One reason for this negative trend was the
decline of sponsored group delegates (2013:
1143; 2014: 772; 2015: 518). The “top 20”
countries of participants registered were as
follows: United Kingdom (170 participants),
Germany (125), Belgium (113), Spain (109),
Greece (104), France (101), The Netherlands
(81), Italy (71), Brazil (55), United States
(51), Turkey (49), Romania (46), Portugal
(43), Switzerland (43), Saudi Arabia (40),
Finland (36), Czech Republic (35), Austria
(34), Bangladesh (33) and Russia (31). Ten
percent of participants came from East Asia
and Pacific (stable since 2009).
A total of 961 abstracts were submitted; the “top” countries were Spain (98
abstracts), Turkey (94), United Kingdom
(88), Greece (39), India (35), Portugal (32),
Netherlands (29), Germany (27), Italy (24)
and Iran (23).
Figure 1. Both chairs of ESPID2015 (Michael Borte, left, and Volker Schuster, right)
in front of the atrium of the congress center, Leipzig.
The ESPID Reports and Reviews of Pediatric Infectious Diseases series topics, authors and contents are chosen and approved
independently by the Editorial Board of ESPID.
The Pediatric Infectious Disease Journal • Volume 35, Number 2, February 2016
www.pidj.com | 209
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
The Pediatric Infectious Disease Journal • Volume 35, Number 2, February 2016
Borte and Schuster
Overall, the meeting has given global
perspectives on pediatric infections, vaccinations and antimicrobial resistance. A total
of 25 scientific sessions were organized, 17
“meet the professor” sessions and 16 moderated E-Poster Walks. Furthermore, 556
hanging posters were presented, and 12 short
oral presentations were given. The seventeen
“meet the professors” sessions comprised the
topics of methicillin-sensitive Staphylococcus
aureus and methicillin-resistant Staphylococcus aureus infections, pleural empyema in
children, pediatrics in the tropics, management of pediatric HIV, otitis media and tonsillitis, diagnosis of lower respiratory tract
infections, management of invasive infections
after hematopoietic stem cell transplantation
osteomyelitis and septic arthritis, vaccines in
children with chronic conditions and catch up
vaccination in case of delayed immunization,
advances in pathophysiology and management of periodic fever syndromes, prebiotics and probiotics in pediatric infectious diseases, hepatitis A, practical aspects of hospital
hygiene measures, infections by pets and reptiles, fungal infections, pitfalls in diagnosis
and treatment of urinary tract infection and
infections by Bordetella pertussis.
The first 2 days before the official
meeting started with industry-sponsored satellite symposia mainly dedicated to vaccinepreventable diseases and included detailed
discussions about vaccines against influenza,
pneumococcal infection, meningococcal disease, pertussis and varicella. One further satellite symposium raised and answered questions “how to maintain and increase vaccine
acceptance and coverage for all age groups
in the digital era” from the position of the
healthcare professional, the policy maker’s
perspective, the anthropologist’s perspective
and the journalist’s role. Herein, we want to
thank all sponsors for their financial support.
The meeting formally started on
May 14, Thursday, with an ESPID opening ceremony symposium entitled “Emerging Infectious Diseases Outbreaks” (Chairs:
Ronald de Groot, the Netherlands, and
Tobias Tenenbaum, Germany). Albert Osterhaus (the Netherlands) first gave an overview on “Infectious Diseases From Animals
to Humans and From Humans to Animals”
followed by Ilaria Capua (Italy) who spoke
210 | www.pidj.com
on “Emerging Infectious Diseases Between
Reality and Perception.”
Then a short description of the society’s mission was given by ESPID’s President Ronald de Groot, further welcoming
addresses were presented by Michael Borte
and Volker Schuster, followed by representatives of local authorities, and a performance
by an excellent local school band of Leipzig.
During the meeting, the following ESPID
symposiums were given with great resonance
and success:
••
••
••
••
••
••
••
••
••
Global perspectives on arthropod-borne
infections, tick-borne encephalitis in
children (J. Süss, Germany), Lyme disease (F. Strle, Slovenia), West Nile virus
in children (B. Martina, the Netherlands)
Vaccine developments under debate:
Varicella and zoster vaccination (U. Heininger, Switzerland) accelerating clinical
trials for new vaccine development (A. V.
S. Hill, United Kingdom) vaccines of the
future (R. Rappuoli, Italy)
Changing faces of nontuberculous mycobacterial (NTM) infections: Genetic
and clinical aspects of NTM infections
(P. Henneke, Germany), interferon-γ–
release assays for the diagnosis of tuberculous and NTM infections (M. Tebruegge, United Kingdom)
Sepsis and meningitis: Evidence-based
treatment for sepsis in neonates (D.
Isaacs, Australia) and evidence of adjuvant therapies in bacterial meningitis (T.
Tenenbaum, Germany)
Current problems in pediatric infectious
diseases: Clostridium difficile–associated
disease in children (T. Zaoutis, United
States), treatment of multidrug resistance
pathogens in children (S. Ashkenazi, Israel)
Update in diagnostics and treatment of
hepatitis B and C: Hepatitis B (S. Wirth,
Germany) and hepatitis (G. Indolfi, Italy)
Antimicrobial resistance—all you need
to know: Prevention of antimicrobial
resistance in the clinic (J. Kluytmans, the
Netherlands)
Bill Marshall lecture and award: pertussis—a never ending story? (U. Heininger,
Switzerland)
Skin infections: Decoding fever and
rash in children (R. Fölster-Holst,
••
Germany), atopic eczema and the
microbiome (A. Oranje, Netherlands);
skin infections through pets (S. Dobson, Canada)
Hospital-acquired infections: Manipulating the microbiome to prevent hais
(A. Milstone, United States), bundle approaches in the prevention of
nosocomial infections in children (V.
Rosenthal, Argentina), antimicrobial
stewardship in pediatric infectious diseases: the spanish perspective (O. Neth,
Spain)
In an ESPID/European Society for
Immunodeficiencies joint symposium,
a session “infectious clues to primary
immunodeficiency” (Chairs: M. Borte and
V.Schuster, both Leipzig), S. Latour (Paris,
France) presented actual data on primary
immunodeficiency diseases revealed and
triggered by Epstein-Barr virus infection.
A. Cant referred detailed clinical cues to
primary immunodeficiency diseases (Newcastle upon Tyne, United Kingdom). C. Picard (France) thereafter presented an excellent overview on typical infections seen in
innate immune defects. Furthermore, an
ESPID/World Health Organization joint
symposium about Ebola and measles and
an ESPID/European Scientific Working
group on Influenza joint symposium on
influenza vaccination of children: “a critical appraisal in a pro/con style scientific
debate” were excellent organized, presented and intensively discussed. With the
end of ESPID 2015, we thank everybody
involved in the organization of the meeting,
the ESPID President Ronald de Groot and
the Board for their support, the International Scientific and the Local Organizing
Committee, the very excellent speakers and
active discussants and importantly the delegates and the conference organizers Kenes.
ESPID has further grown as a society. The
meeting now covers the full spectrum of
pediatric infectious disease issues. We urge
you to join us next year as Adam Finn is
already planning an exciting program for
ESPID 2016 in Brighton, United Kingdom,
May 10–14, 2016 (see http://espid2016.
kenes.com/). We sincerely hope to see you
there!
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2015 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.